Goniothalamin induces cell cycle-specific apoptosis by modulating the redox status in MDA-MB-231 cells

Wen-Ying Chen1, Chin-Chung Wu, Yu-Hsuan Lan

  • 1Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung City, Taiwan.

Insights

Goniothalamin, a natural compound, triggers cancer cell death by disrupting redox balance and degrading cdc25C, leading to cell cycle arrest at the G(2)/M phase in breast cancer cells.

Area of Science:

  • Natural Product Chemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Goniothalamin is a natural styryl-lactone with potential anticancer properties.
  • The precise mechanism of goniothalamin's action in cancer cells requires further elucidation.

Purpose of the Study:

  • To investigate the mechanism of action of goniothalamin in human breast cancer MDA-MB-231 cells.
  • To determine the role of intracellular redox balance and cdc25C degradation in goniothalamin-induced cytotoxicity.

Main Methods:

  • Cell cycle analysis using flow cytometry.
  • Measurement of intracellular reactive oxygen species (ROS) and free thiol content.
  • Assessment of cdc25C protein levels and degradation.
  • Pharmacological manipulation of redox balance using N-acetylcysteine and dl-buthionine-(S,R)-sulfoximine.

Main Results:

  • Goniothalamin induced significant cell cycle arrest at the G(2)/M phase and apoptosis in MDA-MB-231 cells.
  • Treatment increased intracellular ROS and decreased free thiol content, indicating redox imbalance.
  • Goniothalamin enhanced cdc25C degradation, correlating with cell cycle arrest and apoptosis.
  • Antioxidant and glutathione synthesis inhibitor modulated goniothalamin's effects on cell cycle and apoptosis.

Conclusions:

  • Goniothalamin disrupts intracellular redox balance, leading to cdc25C degradation.
  • This mechanism results in cell cycle arrest and apoptosis, primarily at the G(2)/M phase.
  • Goniothalamin represents a promising agent for breast cancer therapy, acting via redox-sensitive pathways.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...